NCT00502528View on ClinicalTrials.gov

Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2012

Conditions
ST-Elevation Myocardial Infarction
Interventions
DRUG

Placebo

Peri-interventional

DRUG

BQ-123

Peri-interventional

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00502528 - Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter